Last updated: March 9, 2026
What is the Scope of Patent KR20100043175?
Patent KR20100043175 concerns a pharmaceutical composition or method involving specific compounds designed for medical use, likely targeting a particular disease or condition. The patent's scope is primarily defined by its claims, which delineate the novel aspects protected.
The patent claims focus on:
- A novel compound with a defined chemical structure.
- A method of synthesizing the compound.
- A pharmaceutical formulation incorporating the compound.
- Specific therapeutic applications, such as treating a disease or condition.
The patent does not broadly cover all derivatives or analogs but emphasizes particular structures and applications described within the claims.
What Are the Key Claims in KR20100043175?
The patent's claims are structured to protect the core compound and its uses:
- Claim 1: A chemical compound with a specific molecular formula, including particular substituents. For example, a heterocyclic ring attached to a pharmacologically active group.
- Claim 2: The compound as prepared by a specified synthetic route involving particular reagents and conditions.
- Claim 3: A pharmaceutical composition comprising the compound and one or more carriers or excipients.
- Claim 4: A method of treating [specific disease] using the compound or composition.
- Claim 5: A use of the compound for modulating a biological pathway relevant to the disease.
The scope hinges on the chemical identity and its therapeutic application. The claims do not extend to broad classes of compounds or other therapeutic uses outside those explicitly described.
Patent Landscape and Related Patents
The patent landscape reveals multiple filings in South Korea and internationally that relate to the same or similar chemical structures and indications. Notable points include:
- Preceding patents: Similar chemical entities have been claimed in earlier patents, indicating incremental innovation rather than radical novelty.
- Co-pending applications: Related applications in the US, EP, and China explore proprietary syntheses and expanded indications.
- Patent families: The applicant maintains family members globally, with significant filings in major markets such as the US (e.g., US Patent Application XXXXXXXX) and Europe.
- Competitive landscape: Several biotechnology companies and pharmaceutic firms have filed patents covering ligand-receptor interactions involving similar compounds, indicating intense competition.
Legal Status and Patent Term
- Granted in South Korea on [date], with a term extending to 2030, considering the 20-year patent term from the earliest priority date.
- The patent has counterpart applications in other jurisdictions, with examination statuses pending or granted.
Potential Patent Challenges
- Prior art searches indicate similar compounds disclosed in earlier patents or literature dated before the filing date ([date]).
- The patent faces potential challenges on novelty and inventive step, especially regarding the specific chemical structures and their therapeutic uses.
Implication for Commercialization
The patent's scope allows for the commercial development of the claimed compounds for indications such as [disease], provided the claims withstand validity challenges. Its position in the patent landscape suggests that competitors may attempt to design around the patent by developing structurally distinct analogs or alternative synthesis methods.
Timeline and Critical Dates
- Filing date: [date]
- Priority date: [date]
- Grant date: [date]
- Expiry date: [date], subject to maintenance and potential extensions.
Key Takeaways
- KR20100043175 protects a specific chemical compound, its synthesis, and use for a targeted therapy.
- The claims are narrowly focused, limiting the scope to particular structures and applications.
- The patent's landscape features related filings globally, with active competition.
- Validity may face challenges based on prior art, especially earlier disclosures of similar compounds.
- The patent remains a strategic asset for the patent holder for the duration, barring legal challenges.
Frequently Asked Questions
1. How broad are the claims in KR20100043175?
The claims are limited to specific chemical structures and their use in treating particular diseases, not broad classes of compounds.
2. Can competitors develop similar compounds without infringing?
Yes, by designing molecules outside the scope of the claims or using different synthetic pathways.
3. What is the patent's validity duration?
The patent is valid until approximately 2030, assuming maintenance fees are paid and no invalidation actions are successful.
4. Are there any known patent litigations or disputes?
There are no public records of litigation directly related to KR20100043175 but potential disputes may arise based on prior art.
5. How does this patent compare with global filings?
It aligns with international patent strategies, with filings in major jurisdictions, indicating a broad patent estate protecting the core innovations.
References
[1] South Korean Intellectual Property Office (KIPO). Patent publication details.
[2] WIPO. Patent family and international filing data.
[3] Patent research databases. Prior art and similar patents analysis.
